# Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma

> **NCT01729338** · PHASE2 · TERMINATED · sponsor: **Duke University** · enrollment: 17 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** Velcade
- **DRUG:** Cyclophosphamide
- **DRUG:** Revlimid

## Key facts

- **NCT ID:** NCT01729338
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-12-19
- **Primary completion:** 2015-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-05-31

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01729338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01729338, "Velcade + Cyclophosphamide in Newly Diagnosed Multiple Myeloma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01729338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*